Global In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Region: Trend Forecast and Growth Opportunity

August 2022 | 194 pages | ID: GCB9EF1FFCABEN
GMD Research

Abstracts

Global in vitro diagnostics (IVD) market will reach $148,393.3 million by 2031, growing by 6.3% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing.

Highlighted with 84 tables and 96 figures, this 194-page report “Global In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Instruments & Devices
• Disposable IVD Devices
• Reusable IVD Devices
• Reagents & Kits
• Software & Services

Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Clinical Chemistry
• Molecular Diagnostics
• Immuno Diagnostics
• Hematology
• Tissue Diagnostics
• Microbiology
• Coagulation and Hemostasis
• Urinalysis
• Other Technologies

By Sample Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Blood
• Mucus
• Urine
• Other Sample Types

By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Infectious Diseases
• Diabetes
• Cancer/Oncology
• Cardiology
• Autoimmune Disease
• Nephrology
• Drug Testing
• HIV/AIDS
• Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Diagnostic Laboratories
• Hospitals and Clinics
• Homecare Settings
• Point-of-Care (POC) Settings
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE?Saudi Arabia, South Africa and Rest of MEA)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories, Inc.

Agilent Technologies, Inc.

Arkray Inc.

Becton, Dickinson and Company

Biomerieux SA

Bio-Rad Laboratories Inc.

Danaher Corporation

DiaSorin SpA (Luminex Corporation)

Epic Systems Corporation

F. Hoffmann-La Roche Ltd.

Genpact Limited

Grifols SA

IBM Corporation

Mckesson Corporation

Ortho Clinical Diagnostics Inc.

Qiagen NV

Quest Diagnostics Inc.

Quidel Corporation

Roche Diagnostics

Siemens Healthineers

Sysmex Corporation

Thermo Fisher Scientific Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT

3.1 Market Overview by Product
3.2 Instruments & Devices
  3.2.1 Disposable IVD Devices
  3.2.2 Reusable IVD Devices
3.3 Reagents & Kits
3.4 Software & Services

4 SEGMENTATION OF GLOBAL MARKET BY TECHNOLOGY

4.1 Market Overview by Technology
4.2 Clinical Chemistry
4.3 Molecular Diagnostics
4.4 Immuno Diagnostics
4.5 Hematology
4.6 Tissue Diagnostics
4.7 Microbiology
4.8 Coagulation and Hemostasis
4.9 Urinalysis
4.10 Other Technologies

5 SEGMENTATION OF GLOBAL MARKET BY SAMPLE TYPE

5.1 Market Overview by Sample Type
5.2 Blood
5.3 Mucus
5.4 Urine
5.5 Other Sample Types

6 SEGMENTATION OF GLOBAL MARKET BY APPLICATION

6.1 Market Overview by Application
6.2 Infectious Diseases
6.3 Diabetes
6.4 Cancer/Oncology
6.5 Cardiology
6.6 Autoimmune Disease
6.7 Nephrology
6.8 Drug Testing
6.9 HIV/AIDS
6.10 Other Applications

7 SEGMENTATION OF GLOBAL MARKET BY END USER

7.1 Market Overview by End User
7.2 Diagnostic Laboratories
7.3 Hospitals and Clinics
7.4 Homecare Settings
7.5 Point-of-Care (POC) Settings
7.6 Other End Users

8 SEGMENTATION OF GLOBAL MARKET BY REGION

8.1 Geographic Market Overview 2021-2031
8.2 North America Market 2021-2031 by Country
  8.2.1 Overview of North America Market
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 European Market 2021-2031 by Country
  8.3.1 Overview of European Market
  8.3.2 Germany
  8.3.3 U.K.
  8.3.4 France
  8.3.5 Spain
  8.3.6 Italy
  8.3.7 Netherlands
  8.3.8 Rest of European Market
8.4 Asia-Pacific Market 2021-2031 by Country
  8.4.1 Overview of Asia-Pacific Market
  8.4.2 Japan
  8.4.3 China
  8.4.4 Australia
  8.4.5 India
  8.4.6 South Korea
  8.4.7 Rest of APAC Region
8.5 South America Market 2021-2031 by Country
  8.5.1 Argentina
  8.5.2 Brazil
  8.5.3 Chile
  8.5.4 Rest of South America Market
8.6 MEA Market 2021-2031 by Country
  8.6.1 UAE
  8.6.2 Saudi Arabia
  8.6.3 South Africa
  8.6.4 Other National Markets

9 COMPETITIVE LANDSCAPE

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Global In Vitro Diagnostics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in Global In Vitro Diagnostics Market
Table 6. Global In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 7. Global In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn
Table 8. Global In Vitro Diagnostics Market by Technology, 2021-2031, $ mn
Table 9. Global In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn
Table 10. Global In Vitro Diagnostics Market by Application, 2021-2031, $ mn
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-2022
Table 12. Global In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 13. Global In Vitro Diagnostics Market by Region, 2021-2031, $ mn
Table 14. Leading National In Vitro Diagnostics Market, 2021 and 2031, $ mn
Table 15. North America In Vitro Diagnostics Market by Country, 2021-2031, $ mn
Table 16. U.S. In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 17. U.S. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 18. U.S. In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 19. Canada In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 20. Canada In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 21. Canada In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 22. Mexico In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 23. Mexico In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 24. Mexico In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 25. Europe In Vitro Diagnostics Market by Country, 2021-2031, $ mn
Table 26. Germany In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 27. Germany In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 28. Germany In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 29. U.K. In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 30. U.K. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 31. U.K. In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 32. France In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 33. France In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 34. France In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 35. Spain In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 36. Spain In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 37. Spain In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 38. Italy In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 39. Italy In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 40. Italy In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 41. Netherlands In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 42. Netherlands In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 43. Netherlands In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 44. In Vitro Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn
Table 45. APAC In Vitro Diagnostics Market by Country, 2021-2031, $ mn
Table 46. Japan In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 47. Japan In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 48. Japan In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 49. China In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 50. China In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 51. China In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 52. Australia In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 53. Australia In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 54. Australia In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 55. India In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 56. India In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 57. India In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 58. South Korea In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 59. South Korea In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 60. South Korea In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 61. In Vitro Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 62. South America In Vitro Diagnostics Market by Country, 2021-2031, $ mn
Table 63. Argentina In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 64. Argentina In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 65. Argentina In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 66. Brazil In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 67. Brazil In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 68. Brazil In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 69. Chile In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 70. Chile In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 71. Chile In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 72. MEA In Vitro Diagnostics Market by Country, 2021-2031, $ mn
Table 73. UAE In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 74. UAE In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 75. UAE In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 76. Saudi Arabia In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 77. Saudi Arabia In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 78. Saudi Arabia In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 79. South Africa In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 80. South Africa In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 81. South Africa In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 82. Abbott Laboratories, Inc.: Company Snapshot
Table 83. Abbott Laboratories, Inc.: Business Segmentation
Table 84. Abbott Laboratories, Inc.: Product Portfolio

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Global In Vitro Diagnostics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global In Vitro Diagnostics Market
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060
Figure 10. Primary Restraints and Impact Factors of Global In Vitro Diagnostics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Global In Vitro Diagnostics Market
Figure 13. Breakdown of Global In Vitro Diagnostics Market by Product, 2021-2031, % of Revenue
Figure 14. Global Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)
Figure 15. Global In Vitro Diagnostics Market by Product: Instruments & Devices, 2021-2031, $ mn
Figure 16. Global In Vitro Diagnostics Market by Instruments & Devices: Disposable IVD Devices, 2021-2031, $ mn
Figure 17. Global In Vitro Diagnostics Market by Instruments & Devices: Reusable IVD Devices, 2021-2031, $ mn
Figure 18. Global In Vitro Diagnostics Market by Product: Reagents & Kits, 2021-2031, $ mn
Figure 19. Global In Vitro Diagnostics Market by Product: Software & Services, 2021-2031, $ mn
Figure 20. Breakdown of Global In Vitro Diagnostics Market by Technology, 2021-2031, % of Sales Revenue
Figure 21. Global Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)
Figure 22. Global In Vitro Diagnostics Market by Technology: Clinical Chemistry, 2021-2031, $ mn
Figure 23. Global In Vitro Diagnostics Market by Technology: Molecular Diagnostics, 2021-2031, $ mn
Figure 24. Global In Vitro Diagnostics Market by Technology: Immuno Diagnostics, 2021-2031, $ mn
Figure 25. Global In Vitro Diagnostics Market by Technology: Hematology, 2021-2031, $ mn
Figure 26. Global In Vitro Diagnostics Market by Technology: Tissue Diagnostics, 2021-2031, $ mn
Figure 27. Global In Vitro Diagnostics Market by Technology: Microbiology, 2021-2031, $ mn
Figure 28. Global In Vitro Diagnostics Market by Technology: Coagulation and Hemostasis, 2021-2031, $ mn
Figure 29. Global In Vitro Diagnostics Market by Technology: Urinalysis, 2021-2031, $ mn
Figure 30. Global In Vitro Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn
Figure 31. Breakdown of Global In Vitro Diagnostics Market by Sample Type, 2021-2031, % of Sales Revenue
Figure 32. Global Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%)
Figure 33. Global In Vitro Diagnostics Market by Sample Type: Blood, 2021-2031, $ mn
Figure 34. Global In Vitro Diagnostics Market by Sample Type: Mucus, 2021-2031, $ mn
Figure 35. Global In Vitro Diagnostics Market by Sample Type: Urine, 2021-2031, $ mn
Figure 36. Global In Vitro Diagnostics Market by Sample Type: Other Sample Types, 2021-2031, $ mn
Figure 37. Breakdown of Global In Vitro Diagnostics Market by Application, 2021-2031, % of Revenue
Figure 38. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 39. Global In Vitro Diagnostics Market by Application: Infectious Diseases, 2021-2031, $ mn
Figure 40. Global In Vitro Diagnostics Market by Application: Diabetes, 2021-2031, $ mn
Figure 41. Global In Vitro Diagnostics Market by Application: Cancer/Oncology, 2021-2031, $ mn
Figure 42. Global In Vitro Diagnostics Market by Application: Cardiology, 2021-2031, $ mn
Figure 43. Global In Vitro Diagnostics Market by Application: Autoimmune Disease, 2021-2031, $ mn
Figure 44. Global In Vitro Diagnostics Market by Application: Nephrology, 2021-2031, $ mn
Figure 45. Global In Vitro Diagnostics Market by Application: Drug Testing, 2021-2031, $ mn
Figure 46. Global In Vitro Diagnostics Market by Application: HIV/AIDS, 2021-2031, $ mn
Figure 47. Global In Vitro Diagnostics Market by Application: Other Applications, 2021-2031, $ mn
Figure 48. Breakdown of Global In Vitro Diagnostics Market by End User, 2021-2031, % of Revenue
Figure 49. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 50. Global In Vitro Diagnostics Market by End User: Diagnostic Laboratories, 2021-2031, $ mn
Figure 51. Global In Vitro Diagnostics Market by End User: Hospitals and Clinics, 2021-2031, $ mn
Figure 52. Global In Vitro Diagnostics Market by End User: Homecare Settings, 2021-2031, $ mn
Figure 53. Global In Vitro Diagnostics Market by End User: Point-of-Care (POC) Settings, 2021-2031, $ mn
Figure 54. Global In Vitro Diagnostics Market by End User: Other End Users, 2021-2031, $ mn
Figure 55. Global Market Snapshot by Region
Figure 56. Geographic Spread of Worldwide In Vitro Diagnostics Market, 2021-2031, % of Sales Revenue
Figure 57. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)
Figure 58. North American In Vitro Diagnostics Market, 2021-2031, $ mn
Figure 59. Breakdown of North America In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 60. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 61. U.S. In Vitro Diagnostics Market, 2021-2031, $ mn
Figure 62. Canada In Vitro Diagnostics Market, 2021-2031, $ mn
Figure 63. In Vitro Diagnostics Market in Mexico, 2021-2031, $ mn
Figure 64. European In Vitro Diagnostics Market, 2021-2031, $ mn
Figure 65. Breakdown of European In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 66. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 67. In Vitro Diagnostics Market in Germany, 2021-2031, $ mn
Figure 68. In Vitro Diagnostics Market in U.K., 2021-2031, $ mn
Figure 69. In Vitro Diagnostics Market in France, 2021-2031, $ mn
Figure 70. In Vitro Diagnostics Market in Spain, 2021-2031, $ mn
Figure 71. In Vitro Diagnostics Market in Italy, 2021-2031, $ mn
Figure 72. In Vitro Diagnostics Market in Netherlands, 2021-2031, $ mn
Figure 73. In Vitro Diagnostics Market in Rest of Europe, 2021-2031, $ mn
Figure 74. Asia-Pacific In Vitro Diagnostics Market, 2021-2031, $ mn
Figure 75. Breakdown of APAC In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 76. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 77. In Vitro Diagnostics Market in Japan, 2021-2031, $ mn
Figure 78. In Vitro Diagnostics Market in China, 2021-2031, $ mn
Figure 79. In Vitro Diagnostics Market in Australia, 2021-2031, $ mn
Figure 80. In Vitro Diagnostics Market in India, 2021-2031, $ mn
Figure 81. In Vitro Diagnostics Market in South Korea, 2021-2031, $ mn
Figure 82. In Vitro Diagnostics Market in Rest of APAC, 2021-2031, $ mn
Figure 83. South America In Vitro Diagnostics Market, 2021-2031, $ mn
Figure 84. Breakdown of South America In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 85. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 86. In Vitro Diagnostics Market in Argentina, 2021-2031, $ mn
Figure 87. In Vitro Diagnostics Market in Brazil, 2021-2031, $ mn
Figure 88. In Vitro Diagnostics Market in Chile, 2021-2031, $ mn
Figure 89. In Vitro Diagnostics Market in Rest of South America, 2021-2031, $ mn
Figure 90. In Vitro Diagnostics Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 91. Breakdown of MEA In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 92. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 93. In Vitro Diagnostics Market in UAE, 2021-2031, $ mn
Figure 94. In Vitro Diagnostics Market in Saudi Arabia, 2021-2031, $ mn
Figure 95. In Vitro Diagnostics Market in South Africa, 2021-2031, $ mn
Figure 96. Growth Stage of Global In Vitro Diagnostics Industry over the Forecast Period